Why are we still not on track to end TB despite decades of scaling up TB services?

The global effort to eradicate tuberculosis (TB) has been ongoing for decades, with significant investments in scaling up TB services. However, despite these efforts, the world is still not on track to end TB. According to the World Health Organization (WHO), TB remains one of the top 10 causes of death worldwide, claiming over 1.5 million lives in 2020 alone. The WHO has set a target to end TB by 2030, but progress has been slow, with only a 2% reduction in TB incidence between 2015 and 2020.

The main reasons for the slow progress include inadequate funding, lack of access to quality TB care, and the emergence of drug-resistant TB. The WHO estimates that an additional $13 billion is needed annually to achieve the TB end goal. In addition, the COVID-19 pandemic has further exacerbated the TB crisis, with many countries diverting resources to respond to the pandemic.

Despite these challenges, there are reasons to be optimistic. The WHO has launched the 'Yes! We Can End TB' initiative, which aims to accelerate progress towards the TB end goal. The initiative is led by countries and powered by people, with a focus on increasing access to quality TB care, improving diagnosis and treatment, and strengthening health systems.

In addition, there are many organizations and individuals working tirelessly to combat TB. For example, the Global Fund to Fight AIDS, Tuberculosis and Malaria has been instrumental in providing funding and support to countries to scale up TB services. Similarly, Doctors Without Borders/Médecins Sans Frontières (MSF) has been providing medical care and support to people affected by TB.

In conclusion, while progress has been slow, there are many reasons to be optimistic about the fight against TB. With increased funding, improved access to quality TB care, and a renewed commitment to ending TB, we can make significant progress towards achieving the TB end goal.

The fight against TB has significant cultural and societal implications. TB is a major public health concern, particularly in low- and middle-income countries where access to quality healthcare is limited. The disease disproportionately affects vulnerable populations, including people living with HIV/AIDS, migrants, and marginalized communities.

The cultural significance of TB is also reflected in the many organizations and initiatives working to combat the disease. For example, the Stop TB Partnership is a global coalition of organizations, governments, and individuals working together to accelerate progress towards the TB end goal. Similarly, the TB Alliance is a non-profit organization dedicated to developing new TB treatments and diagnostics.

In addition, the fight against TB has significant economic implications. According to the WHO, TB costs the global economy over $1 billion annually in lost productivity and healthcare costs. Therefore, ending TB is not only a moral imperative but also a critical economic priority.